HKSE - Delayed Quote • HKD
Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
At close: 3:59 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
841,545.000
841,545.000
841,586.000
705,456.000
622,250.000
Cost of Revenue
257,499.000
257,499.000
193,551.000
126,186.000
91,512.000
Gross Profit
584,046.000
584,046.000
648,035.000
579,270.000
530,738.000
Operating Expense
424,767.000
424,767.000
494,157.000
443,450.000
417,188.000
Operating Income
159,279.000
159,279.000
153,878.000
135,820.000
113,550.000
Net Non Operating Interest Income Expense
32,605.000
32,605.000
34,830.000
33,241.000
27,472.000
Pretax Income
198,314.000
198,314.000
197,345.000
177,273.000
150,041.000
Tax Provision
50,107.000
50,107.000
3,780.000
33,990.000
23,483.000
Net Income Common Stockholders
148,207.000
148,207.000
193,565.000
143,283.000
126,558.000
Diluted NI Available to Com Stockholders
148,207.000
148,207.000
193,565.000
143,283.000
126,558.000
Basic EPS
0.26
--
0.35
0.26
0.23
Diluted EPS
0.26
--
0.35
0.26
0.23
Basic Average Shares
560,250.000
--
560,250.000
560,250.000
560,250.000
Diluted Average Shares
560,250.000
--
560,250.000
560,250.000
560,250.000
Total Operating Income as Reported
198,829.000
198,829.000
197,822.000
177,617.000
150,754.000
Total Expenses
682,266.000
682,266.000
687,708.000
569,636.000
508,700.000
Net Income from Continuing & Discontinued Operation
148,207.000
148,207.000
193,565.000
143,283.000
126,558.000
Normalized Income
143,401.636
143,401.636
185,093.435
136,645.554
119,188.433
Interest Income
33,120.000
33,120.000
35,307.000
33,585.000
28,185.000
Interest Expense
515.000
515.000
477.000
344.000
713.000
Net Interest Income
32,605.000
32,605.000
34,830.000
33,241.000
27,472.000
EBIT
198,829.000
198,829.000
197,822.000
177,617.000
150,754.000
EBITDA
226,389.000
226,389.000
231,426.000
206,495.000
172,916.000
Reconciled Cost of Revenue
257,499.000
257,499.000
193,551.000
126,186.000
91,512.000
Reconciled Depreciation
27,560.000
27,560.000
33,604.000
28,878.000
22,162.000
Net Income from Continuing Operation Net Minority Interest
148,207.000
148,207.000
193,565.000
143,283.000
126,558.000
Total Unusual Items Excluding Goodwill
6,430.000
6,430.000
8,637.000
8,212.000
8,737.000
Total Unusual Items
6,430.000
6,430.000
8,637.000
8,212.000
8,737.000
Normalized EBITDA
219,959.000
219,959.000
222,789.000
198,283.000
164,179.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
1,624.636
1,624.636
165.435
1,574.554
1,367.433
12/31/2020 - 5/24/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade